广州新花城拥有的国内中药一类新药银杏内酯B注射液是目前*的银杏单体注射液,国家“十一五”重大新药创制项目。目前银杏内酯B已进入新药申请阶段,如获得新药证书,将成为国际上*明确治疗成份的银杏类制剂,而广州新花城作为银杏内酯B注射液的生产基地,将为公司日后利润作出较大贡献,具有重要的战略意义。
What does 广州誉东健康制药有限公司 require? Who is 广州誉东健康制药有限公司 hiring? 招聘类别经营管理类占比最多占76.9%,其次是销售类占69.2%。什么学历能进?本科占比最多占69.2%,其次是大专占30.8%。工作经验有什么要求?5-10年占比最多占38.5%,其次是不限占30.8%。工作地区在哪?福州占比最多占30.8%,其次是广州占30.8%。 Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows